Do we need adjuvant treatment for rectal cancer?

Annals of Medicine

Volumn 29, Issue 2, 1997, Pages 91-93

  Sjödahl, Rune ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EDRECOLOMAB; FLUOROURACIL; LEVAMISOLE;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; HUMAN; LIVER TOXICITY; NEUROTOXICITY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; SURGICAL TECHNIQUE;

EID: 0030961270     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899709113695     Document Type: Editorial

References (14)

1. Swedish Rectal Cancer Trial. Preoperative radiotherapy improves survival in resectable rectal carcinoma - final report from a nationwide Swedish trial. N Engl J Med (in press).
2. Gerard A, Buyse M, Nordlinger B, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organisation for Research and Treatment of Cancer (EORTC). Ann Surg 88; 208: 606-14.
3. Cedermark B, Johansson H, Rutqvist L-E, Wilking N, The Stockholm Colorectal Cancer Study Group. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Cancer 95; 75: 2269-75.
4. Swedish Rectal Cancer Trial. Initial report from a Swedish multicenter study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg 93; 80: 1333-6.
5. Holm T, Singnomklau T, Rutqvist L-E, Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer 96; 78: 968-76.
6. Moertel CG, Fleming TR, MacDonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 95; 122: 321-6.
7. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 90; 264: 1444-50.
8. IMPACT (International Multicentre Pooled Analysis of Colon Cancer Trials) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 95; 345: 939-44.
9. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 91; 324: 709-15.
10. Riethmüller G, Schneider-Gädicke E, Schlimok G, et al. for The German Cancer Aid 17-1A Study Group. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 94; 343: 1177-83.
11. Mac-Farlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 93; 341: 457-60.
12. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 94; 344: 707-11.
13. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of rectal cancer. J Am Coll Surg 95; 181: 335-46.
14. Arbman G, Nilsson E, Hallböök O, Sjödahl R. Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 96; 83: 375-9.